D.E. Shaw & Co’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2M | Buy |
554,957
+11,680
| +2% | +$594K | 0.02% | 569 |
|
|
2025
Q1 | $24.5M | Buy |
543,277
+385,925
| +245% | +$17.4M | 0.02% | 594 |
|
|
2024
Q4 | $6.51M | Buy |
+157,352
| New | +$6.51M | ﹤0.01% | 1178 |
|
|
2024
Q1 | – | Sell |
-22,178
| Closed | -$655K | – | 3296 |
|
|
2023
Q4 | $655K | Sell |
22,178
-1,146
| -5% | -$33.8K | ﹤0.01% | 2263 |
|
|
2023
Q3 | $737K | Buy |
+23,324
| New | +$737K | ﹤0.01% | 2172 |
|
|
2022
Q4 | – | Sell |
-36,145
| Closed | -$759K | – | 3709 |
|
|
2022
Q3 | $759K | Buy |
36,145
+11,309
| +46% | +$237K | ﹤0.01% | 2681 |
|
|
2022
Q2 | $483K | Buy |
+24,836
| New | +$483K | ﹤0.01% | 3053 |
|
|
2020
Q3 | – | Sell |
-10,581
| Closed | -$206K | – | 2694 |
|
|
2020
Q2 | $206K | Buy |
+10,581
| New | +$206K | ﹤0.01% | 2443 |
|